本月病例2：慢性嗜酸性粒细胞性肺炎（CEP）：英夫利昔单抗治疗的罕见表现
Lessons of the month 2: Chronic eosinophilic pneumonia (CEP): A rare manifestation of infliximab therapy.
作者信息
Nadeem Iftikhar, Khatana Usman, Rasool Masood Ur, Wasil Asma, Azher Mohammed
机构信息
Bedford Hospital, Bedford, UK
Bedford Hospital, Bedford, UK.
出版信息
Clin Med (Lond). 2020 Jul;20(4):435-437. doi: 10.7861/clinmed.2020-0271.
Abstract
We present a rare and unusual case of 22-year-old man who was on infliximab therapy for his uncontrolled ulcerative colitis. Infliximab was stopped as he didn't get any benefit from it and he ended up having subtotal colectomy and ileostomy. He presented with shortness of breath and eosinophilia and underwent a number of investigations and finally a diagnosis of chronic eosinophilia secondary to infliximab was made.
摘要
我们报告了一例罕见且不寻常的病例，一名22岁男性因溃疡性结肠炎控制不佳而接受英夫利昔单抗治疗。由于他未从英夫利昔单抗治疗中获益，该药物被停用，最终他接受了次全结肠切除术和回肠造口术。他出现了呼吸急促和嗜酸性粒细胞增多症，并接受了多项检查，最终诊断为英夫利昔单抗继发的慢性嗜酸性粒细胞增多症。
相似文献
1
Lessons of the month 2: Chronic eosinophilic pneumonia (CEP): A rare manifestation of infliximab therapy.本月病例2：慢性嗜酸性粒细胞性肺炎（CEP）：英夫利昔单抗治疗的罕见表现
Clin Med (Lond). 2020 Jul;20(4):435-437. doi: 10.7861/clinmed.2020-0271.
2
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy.英夫利昔单抗三剂量诱导方案治疗重度糖皮质激素难治性溃疡性结肠炎：早期和晚期结局及结肠切除术的预测因素
J Crohns Colitis. 2014 Aug;8(8):852-8. doi: 10.1016/j.crohns.2014.01.006. Epub 2014 Jan 25.
3
Colectomy rate in acute severe ulcerative colitis in the infliximab era.英夫利昔单抗时代急性重症溃疡性结肠炎的结肠切除术发生率。
Dig Liver Dis. 2008 Oct;40(10):821-6. doi: 10.1016/j.dld.2008.03.014. Epub 2008 May 9.
4
Infliximab in ulcerative colitis: the impact of preoperative treatment on rates of colectomy and prescribing practices in the province of British Columbia, Canada.英夫利昔单抗治疗溃疡性结肠炎：术前治疗对不列颠哥伦比亚省结肠切除术率和处方实践的影响，加拿大。
Dis Colon Rectum. 2014 Jan;57(1):83-90. doi: 10.1097/DCR.0000000000000003.
5
Treatment of acute ulcerative colitis with infliximab, a retrospective study from three Danish hospitals.使用英夫利昔单抗治疗急性溃疡性结肠炎：来自丹麦三家医院的回顾性研究。
J Crohns Colitis. 2011 Feb;5(1):28-33. doi: 10.1016/j.crohns.2010.09.004. Epub 2010 Oct 13.
6
Infliximab and complications after colectomy in patients with ulcerative colitis.英夫利昔单抗与溃疡性结肠炎患者结肠切除术后并发症。
J Crohns Colitis. 2012 Apr;6(3):281-6. doi: 10.1016/j.crohns.2011.08.014. Epub 2011 Sep 25.
7
Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review.英夫利昔单抗或环孢素治疗后溃疡性结肠炎患者的结肠切除术发生率：一项系统文献综述
Eur J Gastroenterol Hepatol. 2016 Apr;28(4):369-82. doi: 10.1097/MEG.0000000000000568.
8
Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.英夫利昔单抗治疗溃疡性结肠炎：2000年至2006年牛津地区的治疗结果
Aliment Pharmacol Ther. 2007 May 1;25(9):1055-60. doi: 10.1111/j.1365-2036.2007.03300.x.
9
Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients.英夫利昔单抗治疗慢性活动性溃疡性结肠炎的长期疗效：一项对250例患者的瑞典多中心研究
Aliment Pharmacol Ther. 2017 Feb;45(4):519-532. doi: 10.1111/apt.13893. Epub 2016 Dec 27.
10
Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.英夫利昔单抗挽救治疗环孢素治疗失败的皮质激素难治性溃疡性结肠炎：一项多中心研究。
Aliment Pharmacol Ther. 2012 Jan;35(2):275-83. doi: 10.1111/j.1365-2036.2011.04934.x. Epub 2011 Dec 5.
引用本文的文献
1
Dupilumab and the potential risk of eosinophilic pneumonia: case report, literature review, and FAERS database analysis.度普利尤单抗与嗜酸性粒细胞性肺炎的潜在风险：病例报告、文献回顾和 FAERS 数据库分析。
Front Immunol. 2024 Jan 8;14:1277734. doi: 10.3389/fimmu.2023.1277734. eCollection 2023.
本文引用的文献
1
Pulmonary Eosinophilia Following Infliximab Treatment for Crohn's Disease.英夫利昔单抗治疗克罗恩病后出现的肺部嗜酸性粒细胞增多症。
Gastroenterol Hepatol (N Y). 2006 Aug;2(8):592-596.
2
Hypersensitivity reactions to biological drugs.对生物药物的超敏反应。
J Investig Allergol Clin Immunol. 2014;24(4):212-25; quiz 1p following 225.
3
Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease.英夫利昔单抗治疗克罗恩病后出现弥漫性肺泡出血。
Inflamm Bowel Dis. 2004 May;10(3):274-7. doi: 10.1097/00054725-200405000-00016.
4
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.与英夫利昔单抗（一种肿瘤坏死因子α中和剂）相关的结核病。
N Engl J Med. 2001 Oct 11;345(15):1098-104. doi: 10.1056/NEJMoa011110.
5
Invasive pulmonary aspergillosis associated with infliximab therapy.英夫利昔单抗治疗相关的侵袭性肺曲霉病。
N Engl J Med. 2001 Apr 5;344(14):1099-100.
Zotero 插件